Skip to Content


Paulina Firozi, quoting Rachel Sachs (Academic Fellow Alumna)
Washington Post
March 6, 2019

Read the Full Article

From the article:

"Mitchell said the bill still highlights the 'bipartisan energy' around addressing skyrocketing drug costs.

And Rachel Sachs, an associate professor of law at Washington University in St. Louis, said the GOP senator's proposal puts the onus on drug companies to act.

Drug companies have been 'very successful in demonizing PBMs over the last few years,' she told me. 'Now that it looks like Congress is thinking about giving the pharmaceutical industry what they have asked for on PBMs, the pharmaceutical industry needs to step up to the plate and make serious concessions, or they may face more extreme reactions from Congress.'"

Read more here!

Read the Full Article

Tags

pharmaceuticals   rachel sachs   regulation